Possibility of influence of midazolam sedation on the diagnosis of brain death: Concentrations of active metabolites after cessation of midazolam

Yakugaku Zasshi

Volumn 123, Issue 9, 2003, Pages 811-815

  Hirata, Kiyotaka ^a,b   Matsumoto, Yoshiaki ^b   Kurokawa, Akira ^c   Onda, Miho ^b   Shimizu, Makiko ^b   Fukuoka, Masamichi ^b   Hirano, Masaaki ^a   Yamamoto, Yasuhiro ^a  

^a NIPPON MEDICAL SCHOOL HOSPITAL   (Japan)

^b SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

Active metabolites; Benzodiazepines; Brain death testing; Midazolam; Pharmacokinetics

Indexed keywords

1 HYDROXYMIDAZOLAM GLUCORONIDE; DRUG METABOLITE; MIDAZOLAM; UNCLASSIFIED DRUG; 1-HYDROXYMETHYLMIDAZOLAM; ALPHA HYDROXYMIDAZOLAM; DRUG DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BRAIN BLOOD FLOW; BRAIN DEATH; CLINICAL ARTICLE; DETERIORATION; DRUG BLOOD LEVEL; DRUG INFUSION; DRUG INTOXICATION; DRUG MONITORING; DRUG WITHDRAWAL; FEMALE; HUMAN; KIDNEY FUNCTION; MALE; SEDATION; KIDNEY; MIDDLE AGED; MONITORING; PATHOPHYSIOLOGY; TIME;

ADULT; AGED; BRAIN DEATH; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; KIDNEY; MALE; MIDAZOLAM; MIDDLE AGED; MONITORING, PHYSIOLOGIC; TIME FACTORS;

EID: 0642274946     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.123.811     Document Type: Article

References (15)

1. Wijdicks E. F., N. Engl. J. Med., 344, 1215-1221 (2001).
2. Perkins M. W., Dasta J. F., DeHaven B., Ann. Pharmacother., 23, 316-323 (1989).
3. Boukhabza A., Lugnier A. A., Kintz P., Mangin P., J. Anal. Toxicol., 15, 319-322 (1991).
4. Graham R. J., "Benzodiazepines: Abused Drug Monograph Series," ed. by Yale H. C., Abbott Laboratories, Irving, 1994, pp. 1-22.
5. Ebert U., Oertel R., Kirch W., Clin. Pharmacol. Ther., 67, 538-548 (2000).
6. Oldenhof H., de Jong M., Steenhoek A., Janknegt R., Clin. Pharmacol. Ther., 43, 263-269 (1988).
7. Smith M. T., Eadie M. J., Brophy T. O., Eur. J. Clin. Pharmacol., 19, 271-278 (1981).
8. Wagner B. K., O'Hara D. A., Clin. Pharmacokinet., 33, 426-453 (1997).
9. Pallis C., BMJ, 285, 1558-1560 (1982).
10. Takeuchi K., Acta Neurochir., 105, 82-84 (1990).
11. Yang K. L., Dantzker D. R., Chest, 99, 1037-1038 (1991).
12. Albrecht S., Ihmsen H., Hering W., Geisslinger G., Dingemanse J., Schwilden H., Schuttler J., Clin. Pharmacol. Ther., 65, 630-639 (1999).
13. Fiset P., Lemmens H. L., Egan T. E., Shafer S. L., Stanski D. R., Clin. Pharmacol. Ther., 58, 567-582 (1995).
14. Bauer T. M., Ritz R., Haberthur C., Ha H. R., Hunkeler W., Sleight A. J., Scollo-Lavizzari G., Haefeli W. E., Lancet, 346, 145-147 (1995).
15. Driessen J. J., Vree T. B., Guelen P. J., Acta Anaesthesiol. Belg., 42, 149-155 (1991).